XSHG
603579
Market cap529mUSD
Oct 09, Last price
18.01CNY
1D
1.01%
1Q
1.07%
IPO
-49.08%
Name
Shanghai Rongtai Health Technology Corp Ltd
Chart & performance
P/E
23.75
P/S
2.28
EPS
0.76
Div yield, %
1.96%
Shrs. gr., 5y
0.40%
Rev. gr., 5y
-4.89%
Revenues
1.57b
-1.50%
Net income
151m
-21.49%
CFO
175m
+3.94%
Dividend
Jun 10, 20260.5 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1997 and headquartered in Shanghai, China, Shanghai Rongtai Health Technology Corporation Limited specializes in manufacturing and distributing a diverse array of wellness and relaxation products. Their offerings encompass full-sized massage chairs, compact personal massagers, and various related accessories, catering to customers both within China and across global markets.
Key people
Guangrong Lin
Chairman of the Board · since 2013
Jinhua Liao
Finance Director · since 2021
Jian Kong
Deputy General Manager
Qi Lin
General Manager, Director · since 2013
Junliang Wang
Deputy General Manager, Director · since 2016
Xiaogang Wu
Director
Secretary of the Board, Director · since 2021
Feng Liu
Independent Director
Linsen Liu
Independent Director
Independent Director · since 2025
Shuzhi Xie
Independent Director · since 2022
Jianxin Xu
Independent Director
Yuan Yang
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||